The HHS OIG Proposed Rule to Eliminate Manufacturer Rebates in Part D Will Harm Medicare Advantage

The Department of Health and Human Services’ (HHS) Office of Inspector General (OIG) issued a proposed rule that would eliminate the regulatory safe harbor protection for rebates negotiated between drug manufacturers and pharmacy benefits managers (PBMs) and would create a new safe harbor protection for negotiated point-of-sale discounts.